Hemophilia in children in pediatricss

Reading File

Finding Sources

Searching PubMed

"Hemophilia A" AND children

Searching the Web

CDC hemophilia children diagnosis treatment factor replacement inhibitors gene therapy 2025

Finding Sources

Reading File

Reading Article

PMID: 40838439

Hemophilia in children

Hemophilia is an inherited bleeding disorder caused by deficiency or dysfunction of a clotting factor:

Hemophilia A: factor VIII deficiency, due to an F8 gene variant
Hemophilia B: factor IX deficiency, due to an F9 gene variant

Both are usually X-linked recessive, so they mainly affect boys. Females may be carriers and can sometimes have low factor levels and bleeding symptoms. About one-third of cases result from a new mutation, so a negative family history does not exclude it.
Thompson & Thompson Genetics and Genomics in Medicine, 9th ed., p. 501.

Severity

Severity	Factor VIII/IX activity	Typical presentation
Severe	<1%	Spontaneous joint and muscle bleeding
Moderate	1%-5%	Bleeding after minor trauma; occasional spontaneous bleeds
Mild	5%-40%	Usually bleeding only after surgery, dental work, or substantial trauma

Thompson & Thompson Genetics and Genomics in Medicine, 9th ed., p. 501.

Clinical features in children

Presentation depends on severity and age:

Prolonged bleeding after circumcision, heel prick, immunization, or surgery
Large bruises, scalp hematoma, or prolonged bleeding after birth trauma
Excessive bleeding after a minor fall or dental procedure
Deep muscle hematomas
Hemarthrosis, especially of knees, ankles, and elbows. This is the characteristic recurrent bleeding manifestation in severe hemophilia.
A child may report tingling, warmth, tightness, or pain in a joint before visible swelling develops.
Recurrent joint bleeding can cause chronic synovitis, loss of movement, deformity, and hemophilic arthropathy.
Serious bleeds: intracranial, neck/throat, abdominal, iliopsoas, or eye bleeding.

A newly mobile toddler with unusual bruising or bleeding out of proportion to an injury should raise suspicion.
Tintinalli’s Emergency Medicine: A Comprehensive Study, Hematologic Emergencies in Infants and Children, pp. 1062-1069.

Diagnosis

History
- Family history of hemophilia or unexplained bleeding
- Bleeding after minor trauma or procedures
- Recurrent painful swollen joints or muscle hematomas
Screening laboratory tests
- aPTT: prolonged
- PT/INR: normal
- Platelet count: normal
Confirmatory tests
- Specific factor VIII assay for hemophilia A
- Specific factor IX assay for hemophilia B
- Mixing study and inhibitor assay if the aPTT does not correct or treatment response is inadequate

The CDC diagnostic overview likewise emphasizes clotting testing followed by factor assays to identify the type and severity.

Treatment

Children should be linked to a pediatric hematologist or hemophilia treatment center.

1. Factor replacement

The main treatment is replacement of the missing factor:

Recombinant factor VIII for hemophilia A
Recombinant factor IX for hemophilia B

It may be given:

On demand to treat a bleed
As regular prophylaxis to prevent bleeds and protect joints

Early prophylaxis is generally preferred for severe disease. A 2025 Cochrane review found that factor prophylaxis in previously untreated or minimally treated children reduced annual joint bleeds and overall bleeding compared with episodic treatment, although certainty was low (Razmpoosh et al., 2025, PMID 40838439).

2. Non-factor prophylaxis

For hemophilia A, subcutaneous non-factor prophylaxis such as emicizumab may be used in appropriate children, including some with inhibitors. Selection and dosing must be directed by the hemophilia team.

3. Mild hemophilia A

Desmopressin (DDAVP) may raise endogenous factor VIII in selected patients with mild hemophilia A.
It does not treat hemophilia B.

4. Adjunctive drugs

Tranexamic acid may help with mucosal bleeding, dental bleeding, or epistaxis when advised by the treating team.
Avoid aspirin and nonselective NSAIDs unless specifically approved, because they impair platelet function.

Inhibitors

Some children develop neutralizing antibodies called inhibitors against infused factor VIII or IX. Suspect an inhibitor when expected factor replacement no longer controls bleeding. Management may require bypassing agents, non-factor treatment where appropriate, and immune tolerance induction under specialist care. Inhibitor risk is especially relevant early in exposure to factor concentrates.

Emergency approach

Treat bleeding urgently if there is suspected:

Head injury, severe headache, vomiting, drowsiness, seizure, or altered behavior
Neck, throat, chest, abdominal, or iliopsoas pain/swelling
Eye trauma
Major trauma
Severe or rapidly expanding joint or muscle bleed

For a child with known hemophilia and concern for a major bleed, factor should be given promptly, ideally before imaging or invasive procedures, in coordination with hematology. “When in doubt, treat” is a commonly used emergency principle.
Tintinalli’s Emergency Medicine: A Comprehensive Study, p. 1076.

Home and preventive care

Maintain regular prophylaxis and keep an individualized emergency plan.
Teach families recognition of early joint and muscle bleeding.
Encourage safe physical activity, physiotherapy, and muscle strengthening.
Avoid high-contact sports when risk is unacceptable; individualized guidance is better than blanket restriction.
Use pressure after venipuncture.
Avoid intramuscular injections where alternatives exist. Routine immunizations are still important and should be planned with the hemophilia team.
Screen and counsel female relatives for carrier status and factor levels.
Ensure dental hygiene to reduce the need for invasive dental procedures.

Key pediatric takeaway

A boy with prolonged bleeding after circumcision, large unexplained bruises, painful swollen joints, or bleeding disproportionate to trauma should be evaluated for hemophilia. Diagnosis is confirmed by factor assay, and early preventive treatment reduces bleeding and helps preserve joint function.

This is a shared conversation. Sign in to Orris to start your own chat.